EUVIMEDEUVIMED entdecken
Crossref

The First Report on Pharmacokinetic/Pharmacodynamic Study of Trimethoprim/Sulfamethoxazole against Staphylococcus aureus with a Neutropenic Murine Thigh Infection Model

Mao Hagihara, Hideo Kato, Shinya Uchida, Rieko Yamashita, Shimako Tanaka, Daisuke Sakanashi, Arufumi Shiota, Nobuhiro Asai, Yusuke Koizumi, Hiroyuki Suematsu, Yuka Yamagishi, Noriyuki Namiki und 1 weitere

Chemotherapy · 2019 · 64 (5-6) · 224-232

DOI: 10.1159/000507540 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemotherapy, online erschienen am 20.05.2020. Verfasst von Mao Hagihara und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Epidemiology and Biomedical Sciences, Aichi Medical University, Aichi, Japan. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

With an increase in the incidence of Staphylococcus aureus infections in the healthcare settings and in the community, trimethoprim/sulfamethoxazole (TMP/SMX) has been suggested as a convenient treatment option. However, the appropriate dosage regimen of TMP/SMX is unclear.

Objective

This study aimed to examine the pharmacokinetics/pharmacodynamics (PK/PD) of TMP/SMX against S. aureus using a neutropenic murine thigh infection model.

Methods

Five S. aureus isolates with TMP/SMX (1:5 fixed ratio) minimum inhibitory concentrations (MICs) of 0.032–64 μg/mL were tested. The antimicrobial efficacy of TMP/SMX (1–689 mg/kg/day: dose shown as SMX dosage) was calculated as the change in bacterial density after 24 h of treatment. The plasma concentrations of TMP/SMX were detected using high-performance liquid chromatography.

Results

After TMP/SMX single dose (130 mg/kg), the half-life, area under the blood concentration curve (AUC0–∞), and the protein binding ratio of SMX were 1.5 h, 718.2 μg h/mL, and 73.0 ± 8.3%, respectively. The free AUC/MIC and free %time (%T) above the MIC of SMX were better correlated with the in vivo antimicrobial activity than Cmax/MIC (free AUC/MIC, R2 = 0.69; free %T > MIC, R2 = 0.71; free Cmax/MIC, R2 = 0.53). The distributed doses (2–3 times per day) of TMP/SMX (130, 260, and 390 mg/kg/day) showed higher antimicrobial activity than the single dosage. However, TMP/SMX did not show its antimicrobial activity at <100% free %T > MIC.

Conclusions

The TMP/SMX treatment demonstrated that the free AUC/MIC of SMX was the better predictor of the PK/PD index of TMP/SMX.

Schlagwörter

Stichwörter der Autor:innen

PharmacodynamicsPharmacokineticsStaphylococcus aureusTrimethoprim/sulfamethoxazole

Autor:innen und Institutionen

  • Department of Molecular Epidemiology and Biomedical Sciences, Aichi Medical University, Aichi, Japan.
  • Department of Clinical Infectious Diseases, Aichi Medical University, Aichi, Japan.
  • Department of Pharmacy Practice and Science, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
  • Department of Clinical Infectious Diseases, Aichi Medical University, Aichi, Japan, mikamo@aichi-med-u.ac.jp.

Zitieren

APA

Hagihara, M., Kato, H., Uchida, S., Yamashita, R., Tanaka, S., Sakanashi, D., Shiota, A., Asai, N., Koizumi, Y., Suematsu, H., Yamagishi, Y., Namiki, N., & Mikamo, H. (2019). The First Report on Pharmacokinetic/Pharmacodynamic Study of Trimethoprim/Sulfamethoxazole against Staphylococcus aureus with a Neutropenic Murine Thigh Infection Model. Chemotherapy, 64(5-6), 224-232. https://doi.org/10.1159/000507540

Vancouver

Hagihara M, Kato H, Uchida S, Yamashita R, Tanaka S, Sakanashi D, et al. The First Report on Pharmacokinetic/Pharmacodynamic Study of Trimethoprim/Sulfamethoxazole against Staphylococcus aureus with a Neutropenic Murine Thigh Infection Model. Chemotherapy. 2019;64(5-6):224-232. doi:10.1159/000507540

BibTeX
@article{Hagihara2019,
  author = {Hagihara, Mao and Kato, Hideo and Uchida, Shinya and Yamashita, Rieko and Tanaka, Shimako and Sakanashi, Daisuke and Shiota, Arufumi and Asai, Nobuhiro and Koizumi, Yusuke and Suematsu, Hiroyuki and Yamagishi, Yuka and Namiki, Noriyuki and Mikamo, Hiroshige},
  title = {The First Report on Pharmacokinetic/Pharmacodynamic Study of Trimethoprim/Sulfamethoxazole against Staphylococcus aureus with a Neutropenic Murine Thigh Infection Model},
  journal = {Chemotherapy},
  year = {2019},
  volume = {64},
  number = {5-6},
  pages = {224--232},
  doi = {10.1159/000507540}
}
Kostenlos starten →